SWOG clinical trial number
SWOG-8092

Use of Human Tumor Cloning System to Select Chemo- therapy for Patients with Ovarian Cancer Refractory to Primary Therapy

Closed
Phase
Published
Abbreviated Title
Use of Human Tumor Cloning System to Select Chemo- therapy for Patients with Ovarian Cancer Refractory to Primary Therapy
Activated
11/21/1980
Closed
10/03/1984

Publication Information Expand/Collapse

1991

A Southwest Oncology Group study on the use of a human tumor cloning assay for predicting response in patients with ovarian cancer.

DD Von Hoff;R Kronmal;SE Salmon;J Turner;JB Green;JS Bonorris;EL Moorhead;HE Hynes;RP Pugh;RJ Belt;DS Alberts Cancer 67(1):20-27

1984

Quality control of a multicenter human tumor cloning system: The Southwest Oncology Group experience.

GM Clark;DD Von Hoff In: Human Tumor Cloning. SE Salmon, JM Trent, eds. Grune & Stratton, 255-265

The Southwest Oncology Group's quality control program for human tumor cloning laboratories. , and the Southwest Oncology Group Committee for Human Tumor Cloning.

GM Clark;DD Von Hoff 4th Conference on Human Tumor Cloning (Tucson, January 8-10)

1982

Long distance transportation of specimens for human tumor cloning.

J Turner;DD Von Hoff;KD Swenerton;E Gafney;SE Rivkin;CA Coltman Jr;AB Cruz ASCO, #C-117

Long-distance transportation of specimens for human tumor cloning.

DD Von Hoff;KD Swenerton;L Hetanen;E Gafney;S Rivkin;S Schuchart;CA Coltman Stem Cells 2:122-128